Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Linsitinib | 0.0033113 | uM | 7 | 2500.00 | 1312.79 | 4282.00 | 4393.50 | 0.9746 | 0.9707 |
| BT-20 | Erlotinib | 3.1623 | uM | 7 | 2500.00 | 1312.79 | 3514.00 | 4393.50 | 0.7998 | 0.7594 |
| BT-20 | Lapatinib | 1 | uM | 7 | 2500.00 | 1312.79 | 4061.00 | 4393.50 | 0.9243 | 0.9117 |
| BT-20 | Lapatinib | 0.31623 | uM | 7 | 2500.00 | 1312.79 | 4281.00 | 4393.50 | 0.9744 | 0.9705 |
| BT-20 | Erlotinib | 10 | uM | 7 | 2500.00 | 1312.79 | 2739.00 | 4393.50 | 0.6234 | 0.5250 |
| BT-20 | Erlotinib | 19.9526 | uM | 7 | 2500.00 | 1312.79 | 2659.00 | 4393.50 | 0.6052 | 0.4993 |
| BT-20 | 17-AAG | 0.0016596 | uM | 7 | 2500.00 | 1312.79 | 4540.00 | 4393.50 | 1.0333 | 1.0380 |
| BT-20 | 17-AAG | 10 | uM | 7 | 2500.00 | 1312.79 | 1233.00 | 4393.50 | 0.2806 | -0.0353 |
| BT-20 | Linsitinib | 0.01 | uM | 7 | 2500.00 | 1312.79 | 4359.00 | 4393.50 | 0.9922 | 0.9910 |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 4497.00 | 4393.50 | 1.0236 | 1.0269 | |
| BT-20 | Linsitinib | 10 | uM | 7 | 2500.00 | 1312.79 | 3270.00 | 4393.50 | 0.7443 | 0.6882 |
| BT-20 | Linsitinib | 19.9526 | uM | 7 | 2500.00 | 1312.79 | 2242.00 | 4393.50 | 0.5103 | 0.3595 |
| BT-20 | Erlotinib | 0.31623 | uM | 7 | 2500.00 | 1312.79 | 4262.00 | 4393.50 | 0.9701 | 0.9654 |
| BT-20 | 17-AAG | 0.0033113 | uM | 7 | 2500.00 | 1312.79 | 4356.00 | 4393.50 | 0.9915 | 0.9902 |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 4345.00 | 4393.50 | 0.9890 | 0.9873 | |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 4575.00 | 4393.50 | 1.0413 | 1.0470 | |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 1.00 | 4393.50 | 0.0002 | -0.9838 | |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 3.00 | 4393.50 | 0.0007 | -0.9695 | |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 3890.00 | 4393.50 | 0.8854 | 0.8651 | |
| BT-20 | 17-AAG | 0.01 | uM | 7 | 2500.00 | 1312.79 | 2528.00 | 4393.50 | 0.5754 | 0.4565 |
| BT-20 | 17-AAG | 0.31623 | uM | 7 | 2500.00 | 1312.79 | 1246.00 | 4393.50 | 0.2836 | -0.0295 |
| BT-20 | 17-AAG | 0.1 | uM | 7 | 2500.00 | 1312.79 | 1292.00 | 4393.50 | 0.2941 | -0.0091 |
| BT-20 | Erlotinib | 0.031623 | uM | 7 | 2500.00 | 1312.79 | 4093.00 | 4393.50 | 0.9316 | 0.9203 |
| BT-20 | Erlotinib | 1 | uM | 7 | 2500.00 | 1312.79 | 3661.00 | 4393.50 | 0.8333 | 0.8013 |
| BT-20 | Linsitinib | 0.31623 | uM | 7 | 2500.00 | 1312.79 | 4304.00 | 4393.50 | 0.9796 | 0.9765 |